Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR-HBV: Safety of Lung Transplant from HBV+ Donors with EVLP UV Light
NCT07189377Phase 4Recruiting
- Sponsor
- University Health Network
- Start
- Sep 2025
- Primary completion
- Aug 2027
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir, hepatitis B immune globulin in hepatitis B (HBV), sponsored by University Health Network. Started Sep 2025; status: recruiting.
02
Drugs
entecavirhepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT07189377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189377.